Table 4. Bivariate association between explanatory variables and polypharmacy status (N = 5639).
Variable | No polypharmacy | Polypharmacy | χ2 test | p-value |
---|---|---|---|---|
Number (%) | Number (%) | |||
Age (years) | 3.76 | 0.152 | ||
65–69 | 565 (25.7) | 1635 (74.3) | ||
70–74 | 341 (22.9) | 1149 (77.1) | ||
75 or more | 476 (24.4) | 1473 (75.6) | ||
Gender | 14.26 | <0.001* | ||
Male | 699 (26.8) | 1905 (73.2) | ||
Female | 683 (22.5) | 2352 (77.5) | ||
Body Mass Index (kg/m2) | 79.47 | <0.001* | ||
Underweight (<18.5) | 27 (30.0) | 63 (70.0) | ||
Normal (18.5–24.9) | 151 (25.0) | 454 (75.0) | ||
Overweight (25–29.9) | 339 (23.5) | 1102 (76.5) | ||
Obese (≥30) | 500 (20.5) | 1941 (79.5) | ||
No. of chronic conditions | 584.61 | <0.001* | ||
Zero | 157 (64.3) | 87 (35.7) | ||
One | 351 (47.2) | 393 (52.8) | ||
Two | 398 (27.2) | 1063 (72.8) | ||
Three | 268 (16.6) | 1342 (83.4) | ||
Four or more | 207 (13.2) | 1365 (86.8) | ||
Hypertension | 282.55 | <0.001* | ||
No | 460 (45.0) | 563 (55.0) | ||
Yes | 922 (20.0) | 3693 (80.0) | ||
Diabetes mellitus | 409.34 | <0.001* | ||
No | 645 (44.1) | 818 (55.9) | ||
Yes | 737 (17.6) | 3439 (82.4) | ||
Dyslipidemia | 102.70 | <0.001* | ||
No | 945 (29.6) | 2249 (70.4) | ||
Yes | 437 (17.9) | 2008 (82.1) | ||
Cardiovascular disease a | 88.95 | <0.001* | ||
No | 1219 (27.3) | 3251 (72.7) | ||
Yes | 163 (13.9) | 1006 (86.1) | ||
Asthma | 42.98 | <0.001* | ||
No | 1185 (26.4) | 3301 (73.6) | ||
Yes | 197 (17.1) | 955 (82.9) | ||
Arthritis b | 2.11 | 0.078 | ||
No | 1147 (24.9) | 3459 (75.1) | ||
Yes | 235 (22.7) | 798 (77.3) | ||
Gastroesophageal reflux disease | 5.68 | 0.009* | ||
No | 1234 (25.0) | 3697 (75.0) | ||
Yes | 148 (20.9) | 560 (79.1) | ||
Mental health conditions c | 4.83 | 0.015* | ||
No | 1351 (24.7) | 4111 (75.3) | ||
Yes | 31 (17.5) | 146 (82.5) |
a Ischemic heart disease, heart failure, arrhythmia, and stroke
b osteoarthritis and rheumatoid arthritis
c depression, anxiety and dementia